Sponsor decision

The purpose of this clinical study is to evaluate the effect of a four-week consumption of a fresh fermented dairy drink containing probiotic strains on Antibiotic-Associated Diarrhea and Gastro-Intestinal disorders in adult subjects treated for Helicobacter pylori eradication.

Inclusion Criteria:

• Subjects who have read and signed the Study Informed Consent Form
• Subjects positive for Helicobacter pylori infection and symptomatic due to Helicobacter pylori infection
• Subjects with an indication, as stated by a Gastroenterologist, for the eradication of Helicobacter pylori

Exclusion Criteria:

• Female subjects with a positive pregnancy test (based on serum test), or planning to become pregnant during the study or breast-feeding women
• Subjects enrolled in another interventional clinical study in the last 4 weeks or in an exclusion period following participation in another clinical trial
• Subject who have a history of alcohol abuse
• Subjects having diarrhea within the preceding 4-weeks
• Subjects with severe life-threatening illness, severe evolutive or chronic pathology
• Immune-suppressed subjects
• Subjects with benign peptic ulcer or pre-malignant or malignant lesion
• Subjects presenting with an infection of the gastrointestinal tract
• Subjects with any past severe gastro-intestinal or metabolic pathology
• Subjects with history of Helicobacter pylori eradication therapy
• Subjects with history of cardiac or renal clinically significant disease
• Subjects that have had any surgery or intervention requiring general anesthesia in the last 4 weeks, or that have any planned
• Subjects with allergy or hypersensitivity against the medication for the eradication of Helicobacter pylori
• Subjects taking treatments likely to interfere with the evaluation of study parameters.
• Subjects with allergy or hypersensitivity to any component of the study products